FDA warns Inova Genomic Tests about illegally marketing genetic tests intended to predict how consumers will respond to specific drugs.
FDA clears a Magstim 510(k) to include intermittent Theta Burst Stimulation as a treatment for Major Depressive Disorder with its Horizon TMS Therapy ...
A Health Affairs article assesses Scott Gottliebs tenure as FDA commissioner in light of three drug policy initiatives and looks ahead to the arrival ...
Departing FDA commissioner Scott Gottlieb tells the Washington Post he will be returning to the American Enterprise Institute to study ways to reduce ...
FDA says it is releasing 30 years of animal medical product adverse events reports and will update the online database quarterly.
Two pro-life medical groups ask FDA to return Mifeprex labeling to its 2000 provisions, overturning changes made in 2016.
Attorney Sara Koblitz says FDA approved a parallel REMS system for one of four generic manufacturers of Gileads Letairis.
Federal Register notice: FDA announces a 5/13 public hearing to discuss access to affordable insulin products and issues related to the development an...